1 hour ago
From Bharti Airtel planning to capitalise its NBFC arm with ₹20,000 crore to drug firm Lupin receiving approval from the European Commission for its biosimilar ranibizumab, these are some of the stocks to watch out ahead of Tuesday's trading session.
1 / 9
Lupin | The drug firm received approval from the European Commission for its biosimilar ranibizumab, Ranluspec (for vials and pre-filled syringes).
2 / 9
BPCL | The state-owned refiner has received an order from the Commissioner of Central Tax and Central Excise, Kochi, confirming a total excise demand of ₹1,816.65 crore.
3 / 9
Bharti Airtel | The communications solutions provider firm announced plans to capitalise its NBFC arm, Airtel Money Limited, with ₹20,000 crore over the next few years.
4 / 9
Patel Engineering | The infrastructure company, in a joint venture, has been declared the lowest bidder for an irrigation project of ₹133.25 crore from Maharashtra Krishna Valley Development Corporation. Patel Engineering's share in the contract is ₹67.96 crore.
5 / 9
HFCL | The technology company has joined a consortium for a Department of Telecommunications -funded research project led by Indian IIT Delhi to advance hollow-core fiber (HCF) technology for next-generation communication networks.
6 / 9
Waaree Energies | The firm received an order to supply 500MW of solar modules from a renowned domestic solar power developer and independent power producer.
7 / 9
Signpost India Ltd | The digital out-of-home (DOOH) media enterprise has been granted exclusive outdoor advertising rights by the Kolkata Municipal Corporation under the ‘Kolkata Streetscape Renaissance’ project through the public-private partnership (PPP) mode in a ₹450-crore deal over 10 years.
8 / 9
Pace Digitek Ltd | The OEM firm's material subsidiary, Lineage Power Private Ltd, has secured a purchase order worth ₹1,587.10 million (including GST) from Reliance Industries for the supply of lithium-ion battery packs.
9 / 9
Chalet Hotels Limited | The company has approved the development of a proposed 330-room luxury hotel along with approximately 36,255 sq ft of commercial and retail space at Madhapur in Hyderabad, with an estimated investment of around ₹632.8 crore.
